These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7781117)

  • 61. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The histology of mastopathy and cumulative ipsilateral breast cancer sequence].
    Prechtel K; Gehm O; Geiger G; Prechtel P
    Pathologe; 1994 Jun; 15(3):158-64. PubMed ID: 8072949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
    Masood S
    Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 68. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
    Shui RH; Cheng YF; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In situ proliferative epithelial lesions of the breast.
    Kamel OW; Kempson RL; Hendrickson MR
    Pathology (Phila); 1992; 1(1):65-102. PubMed ID: 9420916
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New aspects in the histological diagnosis of breast carcinoma.
    Shousha S
    Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Studies on the histological classification of proliferative disease of breast and its relation with breast carcinoma].
    Zhang J; Liu H; Liu B
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):43-5. PubMed ID: 7781117
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.